Tagprescribing

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia 2006 – 2018

C

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia between 2006 and 2018: A population‐based study Luke E. Grzeskowiak,  Helen Calabretto, Natalie Amos, Danielle Mazza, Jenni Ilomaki ANZJOG First published: 23 October 2020,  Abstract: Background Long‐acting reversible contraceptives (LARCs) are promoted internationally as a key strategy for reducing unintended...

Accessing pharmacotherapy (opioid replacement therapy) during COVID-19

A

Alcohol and Drug Foundation (Australia), April 27th 2020 There are now new challenges for people who access opioid replacement therapy (ORT) due to the COVID-19 (coronavirus) pandemic. Many may be experiencing anxiety and fear due to COVID-19 and trying to reduce and mitigate these feelings is vital. In most cases, people who are on ORT are required to visit their health clinic or pharmacy on a...

U.S. FDA Approves Evofem Biosciences’ Phexxi™, the First Non-Hormonal Prescription Gel for the Prevention of Pregnancy

U

Evofem Biosciences via PRNewswire, May 22nd 2020  Evofem Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Phexxi is the first non-hormonal, on-demand...

Nurse Practitioner (s100) Prescribing Change

N

Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...

Information about TRUVADA and ATRIPLA delisting

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Emergency contraception awareness in an at‐risk population

E

Hope, D. L., Hattingh, L. and King, M. A. (2019) J Pharm Pract Res. doi:10.1002/jppr.1554 Background Consumer awareness of emergency contraception is generally poor. School leavers (schoolies) engage in risky behaviours, including casual sex and alcohol and drug consumption. Aim The aim of this study was to explore the awareness of an at‐risk population of schoolies regarding the use and...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories